Nawal M. Boukli to Anti-HIV Agents
This is a "connection" page, showing publications Nawal M. Boukli has written about Anti-HIV Agents.
Connection Strength
0.624
-
Rodr?guez-Valent?n M, L?pez S, Rivera M, R?os-Olivares E, Cubano L, Boukli NM. Naturally Derived Anti-HIV Polysaccharide Peptide (PSP) Triggers a Toll-Like Receptor 4-Dependent Antiviral Immune Response. J Immunol Res. 2018; 2018:8741698.
Score: 0.473
-
Cubano LA, Cumba L, del Sep?lveda-Torres LC, Boukli N, R?os-Olivares E. Prevalence of drug resistance and associated mutations in a population of Hiv-1+ Puerto Ricans in 2005. Bol Asoc Med P R. 2010 Jul-Sep; 102(3):13-7.
Score: 0.068
-
Cubano LA, Sep?lveda-Torres Ldel C, Sosa G, Boukli N, Robles R, Rodriguez JW, Guzm?n L, R?os-Olivares E. Prevalence of drug resistance and associated mutations in HIV-positive Puerto Ricans: sex variations. Ethn Dis. 2008; 18(2 Suppl 2):S2-132-6.
Score: 0.057
-
Sep?lveda-Torres LDC, Rishishwar L, Rogers ML, R?os-Olivares E, Boukli N, Jordan IK, Cubano LA. A decade of viral mutations and associated drug resistance in a population of HIV-1+ Puerto Ricans: 2002-2011. PLoS One. 2017; 12(5):e0177452.
Score: 0.027